Insmed names drayton wise chief commercial officer

Bridgewater, n.j. , may 23, 2022 /prnewswire/ -- insmed incorporated (nasdaq: insm), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the appointment of drayton wise as chief commercial officer, effective may 23, 2022.
INSM Ratings Summary
INSM Quant Ranking